Protein Engineering Market Will Record an Upsurge in Revenue during 2022-2028
Stratview Research has published a report on the Protein Engineering Market based on information acquired from reliable sources, qualitative and quantitative research by experts, and insights from industry veterans and key players across the value chain. The report provides a thorough analysis of present and upcoming market trends, market dynamics, factors affecting the industry, and growth strategies. This report also provides an in-depth analysis of the impact of the COVID-19 pandemic on the market.
Market Insights
The protein engineering market was estimated at USD 2.6 billion in 2021 and is likely to grow at a CAGR of 12.49% during 2022-2028 to reach USD 5.96 billion in 2028.
What is protein engineering?
Protein engineering is the process of altering a protein sequence to attain the desired result such as increased stability to the temperature, organic solvents, and/or extremes of pH or a change in the substrate capacity.
COVID-19 Impact
The global pandemic in 2020 shook the whole world significantly impacting almost every industry. However, the protein engineering market saw a significant increase in revenues as Covid-19 boosted the industry due to the implication of protein engineering for producing vaccines and diagnostics for Covid-19.
Market Drivers
The major factors that drive the growth of the market are-
- Increasing investments in synthetic biology,
- mounting focus on protein-based drug development by biotechnology and pharmaceutical companies.
Linchpins in the Protein Engineering Market
After a thorough investigation of the market and its players, market experts have listed some key players in the report. Here is the list -
- Bio-Rad Laboratories, Inc.,
- Thermo Fisher Scientific, Inc.,
- Bruker Corporation,
- Agilent Technologies, Inc.,
- Waters Corporation,
- Danaher Corporation,
- Codexis, Inc.,
- New England Biolabs, Inc.,
- PerkinElmer,
- Innovagen AB,
- GE Healthcare,
- CUSABIO TECHNOLOGY LLC,
- Promega Corporation,
- Merck KGaA,
- GenScript Biotech Corporation,
- Takara Bio, Inc.,
- Enantis S.R.O.,
- InvivoGen,
- Pace Analytical,
- Aspira Chemical,
- Zymeworks, Inc.,
- Abzena, Ltd.,
- PhyNexus, Inc.,
- ProteoGenix,
- Creative Biolabs.
Competitive Analysis:
Understanding the strategies of rivalry is critical and Stratview Research does this for its users. This report includes an analysis of the key competitors, the products/services, the differentiators, and market shares, etc.
Critical Questions Answered in the Report
l What are the key trends in the Protein Engineering Market?
l How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
l What is the impact of COVID-19 on the market?
l What are the key strategies adopted by the major vendors to lead in the Protein Engineering Market?
l What is the market share of the top vendors?
Customization of the Report:
This report can be customized to meet the user’s requirements. Stratview research offers custom research services across the sectors.
For further inquiries, connect with us -
Stratview Research
E-mail: sales@stratviewresearch.com
Direct: +1-313-307-4176
About Us:
Stratview Research is a trusted market intelligence firm providing a wide range of services to multiple clients across a wide array of industries. A strong experienced team of industry veterans and research analysts with a perfect blend of wisdom, have been serving multiple clients across a wide array of industries with >99% client satisfaction rate.
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian